These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16948856)

  • 1. The effects of N-terminal insertion into VSV-G of an scFv peptide.
    Dreja H; Piechaczyk M
    Virol J; 2006 Sep; 3():69. PubMed ID: 16948856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent gene transduction using gammaretroviral and lentiviral vectors pseudotyped with chimeric vesicular stomatitis virus glycoprotein.
    Kameyama Y; Kawabe Y; Ito A; Kamihira M
    J Virol Methods; 2008 Oct; 153(1):49-54. PubMed ID: 18606189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications.
    Farley DC; Iqball S; Smith JC; Miskin JE; Kingsman SM; Mitrophanous KA
    J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
    Bartz SR; Vodicka MA
    Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
    Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
    Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.
    Kuate S; Stahl-Hennig C; Stoiber H; Nchinda G; Floto A; Franz M; Sauermann U; Bredl S; Deml L; Ignatius R; Norley S; Racz P; Tenner-Racz K; Steinman RM; Wagner R; Uberla K
    Virology; 2006 Jul; 351(1):133-44. PubMed ID: 16616946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions.
    Kahl CA; Pollok K; Haneline LS; Cornetta K
    Mol Ther; 2005 Mar; 11(3):470-82. PubMed ID: 15727944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer in human skin with different pseudotyped HIV-based vectors.
    Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
    Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.
    Desmaris N; Bosch A; Salaün C; Petit C; Prévost MC; Tordo N; Perrin P; Schwartz O; de Rocquigny H; Heard JM
    Mol Ther; 2001 Aug; 4(2):149-56. PubMed ID: 11482987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression.
    Yoshida Y; Emi N; Hamada H
    Biochem Biophys Res Commun; 1997 Mar; 232(2):379-82. PubMed ID: 9125185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.
    Nguyen TH; Loux N; Dagher I; Vons C; Carey K; Briand P; Hadchouel M; Franco D; Jouanneau J; Schwall R; Weber A
    Cancer Gene Ther; 2003 Nov; 10(11):840-9. PubMed ID: 14605670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo.
    Kaikkonen MU; Räty JK; Airenne KJ; Wirth T; Heikura T; Ylä-Herttuala S
    Gene Ther; 2006 Feb; 13(4):304-12. PubMed ID: 16267571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus.
    Ohishi M; Shioda T; Sakuragi J
    Virology; 2007 May; 362(1):131-8. PubMed ID: 17258261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analyses of stability of simple and complex retroviral vectors.
    Higashikawa F; Chang L
    Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of glycosaminoglycans in vesicular stomatitis virus G glycoprotein pseudotyped lentiviral vector-mediated gene transfer into airway epithelial cells.
    Copreni E; Castellani S; Palmieri L; Penzo M; Conese M
    J Gene Med; 2008 Dec; 10(12):1294-302. PubMed ID: 18816484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.
    Kremer KL; Dunning KR; Parsons DW; Anson DS
    J Gene Med; 2007 May; 9(5):362-8. PubMed ID: 17380490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells.
    Kaneko H; Suzuki H; Abe T; Miyano-Kurosaki N; Takaku H
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1220-7. PubMed ID: 16979590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein.
    Höfig I; Barth S; Salomon M; Jagusch V; Atkinson MJ; Anastasov N; Thirion C
    Biomaterials; 2014 Apr; 35(13):4204-12. PubMed ID: 24529898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
    Anastasov N; Höfig I; Mall S; Krackhardt AM; Thirion C
    Methods Mol Biol; 2016; 1448():49-61. PubMed ID: 27317172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.